<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29467312</PMID><DateCompleted><Year>2018</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>92</Volume><Issue>9</Issue><PubDate><Year>2018</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Fibronectin Facilitates Enterovirus 71 Infection by Mediating Viral Entry.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e02251-17</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.02251-17</ELocationID><Abstract><AbstractText>Fibronectin (FN) is a high-molecular-weight extracellular matrix protein that contains the RGDS motif, which is required to bind to integrins. Synthetic RGDS peptides have been reported to compete with FN to bind to the cell surface and inhibit the function of FN. Here, we identified that synthetic RGDS peptides significantly inhibit human enterovirus 71 (EV71) infection in cell cultures. In addition, mice treated with RGDS peptides and infected with EV71 had a significantly higher survival rate and a lower viral load than the control group. Because RGDS peptides affect the function of FN, we questioned whether FN may play a role in virus infection. Our study indicates that overexpression of FN enhanced EV71 infection. In contrast, knockout of FN significantly reduced viral yield and decreased the viral binding to host cells. Furthermore, EV71 entry, rather than intracellular viral replication, was blocked by FN inhibitor pretreatment. Next, we found that FN could interact with the EV71 capsid protein VP1, and further truncated-mutation assays indicated that the D2 domain of FN could interact with the N-terminal fragment of VP1. Taken together, our results demonstrate that the host factor FN binds to EV71 particles and facilitates EV71 entry, providing a potential therapy target for EV71 infection.<b>IMPORTANCE</b> Hand, foot, and mouth disease outbreaks have occurred frequently in recent years, sometimes causing severe neurological complications and even death in infants and young children worldwide. Unfortunately, no effective antiviral drugs are available for human enterovirus 71 (EV71), one of the viruses that cause hand, foot, and mouth disease. The infection process and the host factors involved remain unknown, although several receptors have been identified. In this study, we found that the host factor fibronectin (FN) facilitated EV71 replication by interacting with EV71 particles and further mediated their entry. The RGDS peptide, an FN inhibitor, significantly inhibited EV71 replication in both RD cells and mice. In conclusion, our research identified a new host factor involved in EV71 infection, providing a new potential antiviral target for EV71 treatment.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 American Society for Microbiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>He</LastName><ForeName>Qiao-Qiao</ForeName><Initials>QQ</Initials><AffiliationInfo><Affiliation>The State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ren</LastName><ForeName>Sheng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Zhang-Chuan</ForeName><Initials>ZC</Initials><AffiliationInfo><Affiliation>The State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Zhi-Kui</ForeName><Initials>ZK</Initials><AffiliationInfo><Affiliation>The State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Nan-Fang</ForeName><Initials>NF</Initials><AffiliationInfo><Affiliation>The State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China yingzhu@whu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005353">Fibronectins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064113" MajorTopicYN="N">CRISPR-Cas Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005353" MajorTopicYN="N">Fibronectins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055786" MajorTopicYN="N">Gene Knockout Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053586" MajorTopicYN="Y">Virus Internalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EV71</Keyword><Keyword MajorTopicYN="N">fibronectin</Keyword><Keyword MajorTopicYN="N">viral entry</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>10</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29467312</ArticleId><ArticleId IdType="pmc">PMC5899198</ArticleId><ArticleId IdType="doi">10.1128/JVI.02251-17</ArticleId><ArticleId IdType="pii">JVI.02251-17</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kao WJ, Lee D. 2001. In vivo modulation of host response and macrophage behavior by polymer networks grafted with fibronectin-derived biomimetic oligopeptides: the role of RGD and PHSRN domains. Biomaterials 22:2901&#x2013;2909. doi:10.1016/S0142-9612(01)00037-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0142-9612(01)00037-0</ArticleId><ArticleId IdType="pubmed">11561896</ArticleId></ArticleIdList></Reference><Reference><Citation>Hynes RO. 2002. Integrins: bidirectional, allosteric signaling machines. Cell 110:673&#x2013;687. doi:10.1016/S0092-8674(02)00971-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(02)00971-6</ArticleId><ArticleId IdType="pubmed">12297042</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Yao J, Chen J, Wang XN, Zhu TY, Chen LL, Chu P. 2009. Construction of drug screening cell model and application to new compounds inhibiting FITC-fibrinogen binding to CHO cells expressing human alphaIIbbeta3. Eur J Pharmacol 618:1&#x2013;8. doi:10.1016/j.ejphar.2009.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2009.07.011</ArticleId><ArticleId IdType="pubmed">19619528</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabuchi A, Yoshioka A, Higashi T, Shirakawa R, Nishioka H, Kita T, Horiuchi H. 2003. Direct demonstration of involvement of protein kinase Calpha in the Ca2+-induced platelet aggregation. J Biol Chem 278:26374&#x2013;26379. doi:10.1074/jbc.M212407200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M212407200</ArticleId><ArticleId IdType="pubmed">12724315</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon C, Han JR, Park HJ, Hah JS, Kang JL. 2009. Synthetic RGDS peptide attenuates lipopolysaccharide-induced pulmonary inflammation by inhibiting integrin signaled MAP kinase pathways. Respir Res 10:18. doi:10.1186/1465-9921-10-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1465-9921-10-18</ArticleId><ArticleId IdType="pmc">PMC2666640</ArticleId><ArticleId IdType="pubmed">19272161</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X, Gong X, Jiang R, Zhang L, Wang B, Xu G, Wang C, Wan J. 2014. Synthetic RGDS peptide attenuated lipopolysaccharide/D-galactosamine-induced fulminant hepatic failure in mice. J Gastroenterol Hepatol 29:1308&#x2013;1315. doi:10.1111/jgh.12525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgh.12525</ArticleId><ArticleId IdType="pubmed">24476051</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Wan JY, Zhang L, Min S. 2012. Synthetic RGDS peptide attenuates mechanical ventilation-induced lung injury in rats. Exp Lung Res 38:204&#x2013;210. doi:10.3109/01902148.2012.664835.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01902148.2012.664835</ArticleId><ArticleId IdType="pubmed">22452721</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Y, Schwarzbauer JE. 2005. Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol 24:389&#x2013;399. doi:10.1016/j.matbio.2005.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.matbio.2005.06.008</ArticleId><ArticleId IdType="pubmed">16061370</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi S, Leiss M, Moser M, Ohashi T, Kitao T, Heckmann D, Pfeifer A, Kessler H, Takagi J, Erickson HP, Fassler R. 2007. The RGD motif in fibronectin is essential for development but dispensable for fibril assembly. J Cell Biol 178:167&#x2013;178. doi:10.1083/jcb.200703021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200703021</ArticleId><ArticleId IdType="pmc">PMC2064432</ArticleId><ArticleId IdType="pubmed">17591922</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh P, Carraher C, Schwarzbauer JE. 2010. Assembly of fibronectin extracellular matrix. Annu Rev Cell Dev Biol 26:397&#x2013;419. doi:10.1146/annurev-cellbio-100109-104020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cellbio-100109-104020</ArticleId><ArticleId IdType="pmc">PMC3628685</ArticleId><ArticleId IdType="pubmed">20690820</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh P, Schwarzbauer JE. 2012. Fibronectin and stem cell differentiation&#x2014;lessons from chondrogenesis. J Cell Sci 125:3703&#x2013;3712. doi:10.1242/jcs.095786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.095786</ArticleId><ArticleId IdType="pmc">PMC3462078</ArticleId><ArticleId IdType="pubmed">22976308</ArticleId></ArticleIdList></Reference><Reference><Citation>Alderete JF, Benchimol M, Lehker MW, Crouch ML. 2002. The complex fibronectin&#x2013;Trichomonas vaginalis interactions and Trichomonosis. Parasitol Int 51:285&#x2013;292. doi:10.1016/S1383-5769(02)00015-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1383-5769(02)00015-6</ArticleId><ArticleId IdType="pubmed">12243782</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson B, Nair S, Pallas J, Williams MA. 2011. Fibronectin: a multidomain host adhesin targeted by bacterial fibronectin-binding proteins. FEMS Microbiol Rev 35:147&#x2013;200. doi:10.1111/j.1574-6976.2010.00243.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2010.00243.x</ArticleId><ArticleId IdType="pubmed">20695902</ArticleId></ArticleIdList></Reference><Reference><Citation>Klotz SA. 1992. Fungal adherence to the vascular compartment: a critical step in the pathogenesis of disseminated candidiasis. Clin Infect Dis 14:340&#x2013;347. doi:10.1093/clinids/14.1.340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/14.1.340</ArticleId><ArticleId IdType="pubmed">1571448</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzies BE. 2003. The role of fibronectin binding proteins in the pathogenesis of Staphylococcus aureus infections. Curr Opin Infect Dis 16:225&#x2013;229. doi:10.1097/00001432-200306000-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001432-200306000-00007</ArticleId><ArticleId IdType="pubmed">12821812</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann BR, Annis DS, Mosher DF. 2011. Reactivity of the N-terminal region of fibronectin protein to transglutaminase 2 and factor XIIIA. J Biol Chem 286:32220&#x2013;32230. doi:10.1074/jbc.M111.255562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.255562</ArticleId><ArticleId IdType="pmc">PMC3173148</ArticleId><ArticleId IdType="pubmed">21757696</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Ding X, Zhang Y, Bo X, Zhang M, Wang S. 2006. Fibronectin is essential for hepatitis B virus propagation in vitro: may be a potential cellular target? Biochem Biophys Res Commun 344:757&#x2013;764. doi:10.1016/j.bbrc.2006.03.204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.03.204</ArticleId><ArticleId IdType="pubmed">16631116</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Collodi P. 2002. Novel form of fibronectin from zebrafish mediates infectious hematopoietic necrosis virus infection. J Virol 76:492&#x2013;498. doi:10.1128/JVI.76.2.492-498.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.2.492-498.2002</ArticleId><ArticleId IdType="pmc">PMC136842</ArticleId><ArticleId IdType="pubmed">11752139</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurer LM, Tomasini-Johansson BR, Ma W, Annis DS, Eickstaedt NL, Ensenberger MG, Satyshur KA, Mosher DF. 2010. Extended binding site on fibronectin for the functional upstream domain of protein F1 of Streptococcus pyogenes. J Biol Chem 285:41087&#x2013;41099. doi:10.1074/jbc.M110.153692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.153692</ArticleId><ArticleId IdType="pmc">PMC3003407</ArticleId><ArticleId IdType="pubmed">20947497</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu H, Utama A, Onnimala N, Li C, Li-Bi Z, Yu-Jie M, Pongsuwanna Y, Miyamura T. 2004. Molecular epidemiology of enterovirus 71 infection in the Western Pacific Region. Pediatr Int 46:231&#x2013;235. doi:10.1046/j.1442-200x.2004.01868.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1442-200x.2004.01868.x</ArticleId><ArticleId IdType="pubmed">15056257</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardosa MJ, Perera D, Brown BA, Cheon D, Chan HM, Chan KP, Cho H, McMinn P. 2003. Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes. Emerg Infect Dis 9:461&#x2013;468. doi:10.3201/eid0904.020395.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0904.020395</ArticleId><ArticleId IdType="pmc">PMC2957976</ArticleId><ArticleId IdType="pubmed">12702227</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. 2010. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 10:778&#x2013;790. doi:10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordey S, L'Huillier AG, Turin L, Gervaix A, Posfay Barbe K, Kaiser L. 2015. Enterovirus and Parechovirus viraemia in young children presenting to the emergency room: unrecognised and frequent. J Clin Virol 68:69&#x2013;72. doi:10.1016/j.jcv.2015.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2015.05.003</ArticleId><ArticleId IdType="pubmed">26071339</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordey S, Petty TJ, Schibler M, Martinez Y, Gerlach D, van Belle S, Turin L, Zdobnov E, Kaiser L, Tapparel C. 2012. Identification of site-specific adaptations conferring increased neural cell tropism during human enterovirus 71 infection. PLoS Pathog 8:e1002826. doi:10.1371/journal.ppat.1002826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002826</ArticleId><ArticleId IdType="pmc">PMC3406088</ArticleId><ArticleId IdType="pubmed">22910880</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaini Z, McMinn P. 2012. A single mutation in capsid protein VP1 (Q145E) of a genogroup C4 strain of human enterovirus 71 generates a mouse-virulent phenotype. J Gen Virol 93:1935&#x2013;1940. doi:10.1099/vir.0.043893-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.043893-0</ArticleId><ArticleId IdType="pubmed">22647370</ArticleId></ArticleIdList></Reference><Reference><Citation>Strauss M, Filman DJ, Belnap DM, Cheng N, Noel RT, Hogle JM. 2015. Nectin-like interactions between poliovirus and its receptor trigger conformational changes associated with cell entry. J Virol 89:4143&#x2013;4157. doi:10.1128/JVI.03101-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03101-14</ArticleId><ArticleId IdType="pmc">PMC4442392</ArticleId><ArticleId IdType="pubmed">25631086</ArticleId></ArticleIdList></Reference><Reference><Citation>Fricks CE, Hogle JM. 1990. Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding. J Virol 64:1934&#x2013;1945.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC249347</ArticleId><ArticleId IdType="pubmed">2157861</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuthill TJ, Bubeck D, Rowlands DJ, Hogle JM. 2006. Characterization of early steps in the poliovirus infection process: receptor-decorated liposomes induce conversion of the virus to membrane-anchored entry-intermediate particles. J Virol 80:172&#x2013;180. doi:10.1128/JVI.80.1.172-180.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.80.1.172-180.2006</ArticleId><ArticleId IdType="pmc">PMC1317540</ArticleId><ArticleId IdType="pubmed">16352541</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P, Song Z, Qi Y, Feng X, Xu N, Sun Y, Wu X, Yao X, Mao Q, Li X, Dong W, Wan X, Huang N, Shen X, Liang Z, Li W. 2012. Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2. J Biol Chem 287:6406&#x2013;6420. doi:10.1074/jbc.M111.301622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.301622</ArticleId><ArticleId IdType="pmc">PMC3307280</ArticleId><ArticleId IdType="pubmed">22219187</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Koike S. 2011. Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection. J Virol 85:4937&#x2013;4946. doi:10.1128/JVI.02358-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02358-10</ArticleId><ArticleId IdType="pmc">PMC3126200</ArticleId><ArticleId IdType="pubmed">21389126</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogle JM. 2012. A 3D framework for understanding enterovirus 71. Nat Struct Mol Biol 19:367&#x2013;368. doi:10.1038/nsmb.2276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2276</ArticleId><ArticleId IdType="pubmed">22472617</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Chuang H, Yang KD. 2009. Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol J 6:141. doi:10.1186/1743-422X-6-141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-6-141</ArticleId><ArticleId IdType="pmc">PMC2751754</ArticleId><ArticleId IdType="pubmed">19751532</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. 2009. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med 15:794&#x2013;797. doi:10.1038/nm.1961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1961</ArticleId><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang SL, Chou YT, Wu CN, Ho MS. 2011. Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity. J Virol 85:11809&#x2013;11820. doi:10.1128/JVI.00297-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00297-11</ArticleId><ArticleId IdType="pmc">PMC3209289</ArticleId><ArticleId IdType="pubmed">21900167</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Poh CL, Sam IC, Chan YF. 2013. Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J Virol 87:611&#x2013;620. doi:10.1128/JVI.02226-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02226-12</ArticleId><ArticleId IdType="pmc">PMC3536405</ArticleId><ArticleId IdType="pubmed">23097443</ArticleId></ArticleIdList></Reference><Reference><Citation>Su PY, Wang YF, Huang SW, Lo YC, Wang YH, Wu SR, Shieh DB, Chen SH, Wang JR, Lai MD, Chang CF. 2015. Cell surface nucleolin facilitates enterovirus 71 binding and infection. J Virol 89:4527&#x2013;4538. doi:10.1128/JVI.03498-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03498-14</ArticleId><ArticleId IdType="pmc">PMC4442404</ArticleId><ArticleId IdType="pubmed">25673703</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel KP, Bergelson JM. 2009. Receptors identified for hand, foot and mouth virus. Nat Med 15:728&#x2013;729. doi:10.1038/nm0709-728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0709-728</ArticleId><ArticleId IdType="pubmed">19584857</ArticleId></ArticleIdList></Reference><Reference><Citation>Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, Zhang F. 2013. Multiplex genome engineering using CRISPR/Cas systems. Science 339:819&#x2013;823. doi:10.1126/science.1231143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1231143</ArticleId><ArticleId IdType="pmc">PMC3795411</ArticleId><ArticleId IdType="pubmed">23287718</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruoslahti E. 1996. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 12:697&#x2013;715. doi:10.1146/annurev.cellbio.12.1.697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.cellbio.12.1.697</ArticleId><ArticleId IdType="pubmed">8970741</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersel U, Dahmen C, Kessler H. 2003. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials 24:4385&#x2013;4415. doi:10.1016/S0142-9612(03)00343-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0142-9612(03)00343-0</ArticleId><ArticleId IdType="pubmed">12922151</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lorenzi V, Sarra Ferraris GM, Madsen JB, Lupia M, Andreasen PA, Sidenius N. 2016. Urokinase links plasminogen activation and cell adhesion by cleavage of the RGD motif in vitronectin. EMBO Rep 17:982&#x2013;998. doi:10.15252/embr.201541681.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201541681</ArticleId><ArticleId IdType="pmc">PMC4931562</ArticleId><ArticleId IdType="pubmed">27189837</ArticleId></ArticleIdList></Reference><Reference><Citation>Widhe M, Shalaly ND, Hedhammar M. 2016. A fibronectin mimetic motif improves integrin mediated cell biding to recombinant spider silk matrices. Biomaterials 74:256&#x2013;266. doi:10.1016/j.biomaterials.2015.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2015.10.013</ArticleId><ArticleId IdType="pubmed">26461118</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren S, Wang J, Chen TL, Li HY, Wan YS, Peng NF, Gui XE, Zhu Y. 2016. Hepatitis B virus stimulated fibronectin facilitates viral maintenance and replication through two distinct mechanisms. PLoS One 11:e0152721. doi:10.1371/journal.pone.0152721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0152721</ArticleId><ArticleId IdType="pmc">PMC4811540</ArticleId><ArticleId IdType="pubmed">27023403</ArticleId></ArticleIdList></Reference><Reference><Citation>Beer C, Pedersen L. 2007. Matrix fibronectin binds gammaretrovirus and assists in entry: new light on viral infections. J Virol 81:8247&#x2013;8257. doi:10.1128/JVI.00312-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00312-07</ArticleId><ArticleId IdType="pmc">PMC1951278</ArticleId><ArticleId IdType="pubmed">17522212</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Zhang X, Zhang J, Hui L, Wang Y, Wang X. 2012. Effect of fibronectin on HBV infection in primary human fetal hepatocytes in vitro. Mol Med Rep 6:1145&#x2013;1149. doi:10.3892/mmr.2012.1029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2012.1029</ArticleId><ArticleId IdType="pubmed">22895745</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S. 2009. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med 15:798&#x2013;801. doi:10.1038/nm.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Kong XP, Liu H, Cheng LX, Huang JL, Quan L, Wu FY, Hao B, Liu C, Luo B. 2015. Expression of EV71-VP1, PSGL-1 and SCARB2 in tissues of infants with brain stem encephalitis. Fa Yi Xue Za Zhi 31:97&#x2013;101, 104 (In Chinese.)</Citation><ArticleIdList><ArticleId IdType="pubmed">26245084</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Ohka S, Fujii K, Koike S. 2013. Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J Virol 87:3335&#x2013;3347. doi:10.1128/JVI.02070-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02070-12</ArticleId><ArticleId IdType="pmc">PMC3592140</ArticleId><ArticleId IdType="pubmed">23302872</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H, Yoon CS, Kim H, Rah B. 1999. Expression of extracellular matrix components fibronectin and laminin in the human fetal heart. Cell Struct Funct 24:19&#x2013;26. doi:10.1247/csf.24.19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1247/csf.24.19</ArticleId><ArticleId IdType="pubmed">10355875</ArticleId></ArticleIdList></Reference><Reference><Citation>Coolen NA, Schouten KC, Middelkoop E, Ulrich MM. 2010. Comparison between human fetal and adult skin. Arch Dermatol Res 302:47&#x2013;55. doi:10.1007/s00403-009-0989-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00403-009-0989-8</ArticleId><ArticleId IdType="pmc">PMC2799629</ArticleId><ArticleId IdType="pubmed">19701759</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Z, Dong X, Li Y, Zhang Q, Kim C, Song Y, Kang L, Liu Y, Wu K, Wu J. 2014. PolyC-binding protein 1 interacts with 5&#x2032;-untranslated region of enterovirus 71 RNA in membrane-associated complex to facilitate viral replication. PLoS One 9:e87491. doi:10.1371/journal.pone.0087491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0087491</ArticleId><ArticleId IdType="pmc">PMC3906175</ArticleId><ArticleId IdType="pubmed">24489926</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV. 2005. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A 102:9294&#x2013;9299. doi:10.1073/pnas.0503596102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0503596102</ArticleId><ArticleId IdType="pmc">PMC1166622</ArticleId><ArticleId IdType="pubmed">15939869</ArticleId></ArticleIdList></Reference><Reference><Citation>Su PY, Liu YT, Chang HY, Huang SW, Wang YF, Yu CK, Wang JR, Chang CF. 2012. Cell surface sialylation affects binding of enterovirus 71 to rhabdomyosarcoma and neuroblastoma cells. BMC Microbiol 12:162. doi:10.1186/1471-2180-12-162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2180-12-162</ArticleId><ArticleId IdType="pmc">PMC3478995</ArticleId><ArticleId IdType="pubmed">22853823</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>